You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-Glucagon-Like Peptide 2 Receptor (GLP2R) Antibodies

Full name:
anti-Glucagon-Like Peptide 2 Receptor Antibodies (GLP2R)
On www.antibodies-online.com are 94 Glucagon-Like Peptide 2 Receptor (GLP2R) Antibodies from 16 different suppliers available. Additionally we are shipping Glucagon-Like Peptide 2 Receptor Proteins (10) and Glucagon-Like Peptide 2 Receptor Kits (4) and many more products for this protein. A total of 112 Glucagon-Like Peptide 2 Receptor products are currently listed.
Synonyms:
9530092J08Rik, GLP-2, GLP1, GLP2, GRPP
list all antibodies Gene Name GeneID UniProt
GLP2R 2641 P01275
GLP2R 93896 Q5IXF8
GLP2R 60432 Q9Z0W0

Show all species

Show all synonyms

Most Popular Reactivities for anti-Glucagon-Like Peptide 2 Receptor (GLP2R) Antibodies

Select your species and application

anti-Human Antibodies:

anti-Mouse (Murine) Antibodies:

anti-Rat (Rattus) Antibodies:

All available anti-Glucagon-Like Peptide 2 Receptor Antibodies

Go to our pre-filtered search.

Top referenced anti-Glucagon-Like Peptide 2 Receptor Antibodies

  1. Human Monoclonal GLP2R Primary Antibody for ELISA, WB - ABIN395085 : Bailey, Xie, Do, Montpetit, Diaz, Mohan, Keavney, Yusuf, Gerstein, Engert, Anand: Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study. in Diabetes Care 2010 (PubMed)
    Show all 5 references for ABIN395085

  2. Human Polyclonal GLP2R Primary Antibody for DB, EIA - ABIN493012 : Velázquez, Ruiz-Albusac, Blázquez: Glucagon-like peptide-2 stimulates the proliferation of cultured rat astrocytes. in European journal of biochemistry / FEBS 2003 (PubMed)
    Show all 3 references for ABIN493012

  3. Human Polyclonal GLP2R Primary Antibody for EIA, WB - ABIN952529 : Pinheiro, Bulik, Thornton, Sullivan, Root, Bloss, Berrettini, Schork, Kaye, Bergen, Magistretti, Brandt, Crawford, Crow, Fichter, Goldman, Halmi, Johnson, Kaplan, Keel, Klump, La Via, Mitchell, Strober, Rotondo, Treasure, Woodside: Association study of 182 candidate genes in anorexia nervosa. in American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2010 (PubMed)
    Show all 2 references for ABIN952529

  4. Human Polyclonal GLP2R Primary Antibody for WB - ABIN2787698 : Sams, Hastrup, Andersen, Thim: Naturally occurring glucagon-like peptide-2 (GLP-2) receptors in human intestinal cell lines. in European journal of pharmacology 2006 (PubMed)
    Show all 2 references for ABIN2787698

  5. Human Polyclonal GLP2R Primary Antibody for IF, IHC (p) - ABIN122262 : Baldassano, Liu, Qu, Mulè, Wood: Glucagon-like peptide-2 modulates neurally evoked mucosal chloride secretion in guinea pig small intestine in vitro. in American journal of physiology. Gastrointestinal and liver physiology 2010 (PubMed)

More Antibodies against Glucagon-Like Peptide 2 Receptor Interaction Partners

Human Glucagon-Like Peptide 2 Receptor (GLP2R) interaction partners

  1. Glucagon-like Peptide-1 (show GCG Antibodies) Analogues Inhibit Proliferation and Increase Apoptosis of Human Prostate Cancer Cells

  2. The GLP-1 (show GCG Antibodies) secretion after 75 g OGTT was impaired in newly diagnosed T2DM patients, inversely proportional to insulin (show INS Antibodies) resistance and hyperglycemia, and positively correlated with beta-cell function and insulin (show INS Antibodies) sensitivity.

  3. GLP-1 (show GCG Antibodies) secretion increased in response to inflammatory stimuli in humans, which was associated to parameters of glucose metabolism and best predicted by IL6 (show IL6 Antibodies).

  4. Among young and healthy adults, GLP-1 (show GCG Antibodies) levels are strongly and independently related to body fat mass especially in men, but not body mass index or waist circumference.

  5. Glucagon (show GCG Antibodies) circulates in patients without a pancreas and glucose stimulation of the gastrointestinal tract elicits significant hyperglucagonemia in these patients.

  6. There is minor contribution of endogenous GLP-1 and GLP-2 to postprandial lipemia in obese men.

  7. Data suggest that endocrine responses differ between jejunal and gastric enteral feeding, with higher peak plasma CCK (cholecystokinin), PYY (peptide YY), and GLP-1/2 (glucagon-like peptides 1/2) concentrations being attained after jejunal feeding.

  8. Data suggest that capsaicin, an appetite suppressant dietary supplement (here, administered via intraduodenal infusion), does not act via alteration of secretion of satiety hormones GLP-1 (GLP-1) and PYY (peptide YY).

  9. Data show that NCI-H716 cells were immunostained for tumor necrosis factor (show TNF Antibodies) receptor TNFR1 (show TNFRSF1A Antibodies), and TNFalpha (show TNF Antibodies) treatment enhances glucagon-like peptide-1 (GLP-1 (show GCG Antibodies)) secretion.

  10. active GLP-1 (show GCG Antibodies) produced in the islet stimulates cholecystokinin (show CCK Antibodies) production and secretion in a paracrine manner via cyclic AMP (show APRT Antibodies) and CREB (show CREB1 Antibodies).

Mouse (Murine) Glucagon-Like Peptide 2 Receptor (GLP2R) interaction partners

  1. Results suggest that GLP-2 (show GCG Antibodies) protected and improved memory function in LPS (show TLR4 Antibodies)-treated mice, and also had anxiolytic effects due to changes in the 5-HT (show DDC Antibodies) system.

  2. Report gastrointestinal GLP-2 receptor andl limited utility of GLP-2 in the management of inflammatory intestinal disorders.

  3. GLP-2 (show GCG Antibodies) plays a key physiological role in the control of hepatic glucose production through activating PI3K-dependent modulation of membrane excitability and nuclear transcription of POMC (show POMC Antibodies) neurons in the brain.

  4. Data suggest a role for endogenous GLP2 (glucagon-like peptide-2 (show GCG Antibodies)) and GLP2R in adaptation of mucosa of duodenum and jejunum to high-fat diet; results suggest dysregulation of GLP2/GLP2R signaling in obesity due to prolonged high-fat diet.

  5. The data indicated that CNS GLP-2 receptor plays a physiological role in the control of feeding behavior and gastric emptying and that this is mediated probably through the melanocortin system.

  6. Data suggest that the Vip (show Vip Antibodies) gene is not required for induction of a gene expression program linked to small bowel growth after enhancement of GLP-2 receptor signaling.

  7. Disruption of the murine Glp2r impairs Paneth cell function and increases susceptibility to small bowel enteritis

  8. Data show that the GLP-2R is expressed by inhibitory and excitatory neurons, and inhibits the muscle contractility likely by decreasing cholinergic neurotransmission and increasing nitric oxide production.

  9. GLP-2R is not critical for the stimulation/suppression of glucagon (show GCG Antibodies) secretion or glucose homeostasis in normal or lean diabetic mice. In obese mice GLP-2R signaling mediates the normal islet adaptive response required to maintain glucose homeostasis.

  10. Glucagon-like peptide-2 (show GCG Antibodies) potentiates L-type voltage-gated Ca(2 (show CA2 Antibodies)+) channels activity through activating cAMP-dependent protein kinase A signaling, partially stimulating glucose uptake by primary cultured hippocampal neurons.

Cow (Bovine) Glucagon-Like Peptide 2 Receptor (GLP2R) interaction partners

  1. data demonstrate that cattle express proglucagon (show GCG Antibodies) and glucagon-like peptide 2 receptor mRNA primarily in small intestinal and colon tissues

Glucagon-Like Peptide 2 Receptor (GLP2R) Antigen Profile

Antigen Summary

The GLP2 receptor (GLP2R) is a G protein-coupled receptor superfamily member closely related to the glucagon receptor ans GLP1 receptor. Glucagon-like peptide-2 (GLP2) is a 33-amino acid proglucagon-derived peptide produced by intestinal enteroendocrine cells. Like glucagon-like peptide-1 (GLP1) and glucagon itself, it is derived from the proglucagon peptide encoded by the GCG gene. GLP2 stimulates intestinal growth and upregulates villus height in the small intestine, concomitant with increased crypt cell proliferation and decreased enterocyte apoptosis. Moreover, GLP2 prevents intestinal hypoplasia resulting from total parenteral nutrition. GLP2R, a G protein-coupled receptor superfamily member is expressed in the gut and closely related to the glucagon receptor (GCGR) and the receptor for GLP1 (GLP1R).

Alternative names and synonyms associated with Glucagon-Like Peptide 2 Receptor (GLP2R)

  • glucagon-like peptide 2 receptor (GLP2R) antibody
  • glucagon-like peptide 2 receptor (LOC100338519) antibody
  • glucagon (GCG) antibody
  • glucagon-like peptide 2 receptor (Glp2r) antibody
  • 9530092J08Rik antibody
  • GLP-2 antibody
  • GLP1 antibody
  • GLP2 antibody
  • GRPP antibody

Protein level used designations for GLP2R

glucagon-like peptide 2 receptor , glicentin-related polypeptide , glucagon-like peptide 1 , glucagon-like peptide 2 , preproglucagon , GLP-2 receptor , GLP-2-R , GLP-2R , G protein-coupled receptor GLP2R , glucagon-like peptide-2 receptor

GENE ID SPECIES
100073078 Equus caballus
100338519 Oryctolagus cuniculus
2641 Homo sapiens
9340 Homo sapiens
93896 Mus musculus
60432 Rattus norvegicus
489499 Canis lupus familiaris
100515966 Sus scrofa
511942 Bos taurus
Selected quality suppliers for anti-Glucagon-Like Peptide 2 Receptor (GLP2R) Antibodies
Did you look for something else?